ELI LILLY & CO (LLY)
Clinical trial NCT05254743 updates: 1. primary completion date: 2025-06-10 → 2027-10-01 2. enrollment: 662 → 737 participants
Clinical trial NCT05254743 updates: 1. primary completion date: 2025-06-10 → 2027-10-01 2. enrollment: 662 → 737 participants
📉 **NEGATIVE** • Medium confidence analysis (64%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical